This inventor holds 4 USPTO granted patents. Top assignees: Mitsui Petrochemical Industries, Ltd., Mitsui Pharmaceuticals, Inc.. Active years: 1988-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kuga, JP (1988)
- Waki, JP (1989 - 1990)
- Yamaguchi, JP (1994)
Company Filing History:
Years Active: 1988-1994
Title: Koji Kato: Innovator in Pharmaceutical Chemistry
Introduction
Koji Kato is a notable inventor based in Yamaguchi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating neurological diseases and gastric ulcers. With a total of 4 patents, Kato's work has had a meaningful impact on medical science.
Latest Patents
Kato's latest patents include innovative compounds such as novel pyrimidines and their pharmaceutically acceptable salts. These compounds are designed to address neurological diseases affecting both the peripheral and central nervous systems in animals. Another significant patent involves alpha-acyloxyketone derivatives, which serve as intermediates for the production of Cimetidine and related compounds. Cimetidine is known for its effectiveness in controlling gastric acid secretion and treating gastric ulcers.
Career Highlights
Throughout his career, Koji Kato has worked with prominent companies such as Mitsui Petrochemical Industries, Ltd. and Mitsui Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.
Collaborations
Kato has collaborated with esteemed colleagues, including Akira Awaya and Takuo Nakano. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Koji Kato's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile